nach oben

Wiener klinische Wochenschrift

Erschienen in:

03.02.2021 | letter to the editors

Is there an association between hypothyroidism and COVID 19?

A preliminary report

verfasst von: Associate professor of ENT Dr Satvinder Singh Bakshi, MS, DNB, Dr. Vinoth Kumar Kalidoss, MD MPH

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 7-8/2021

Einloggen, um Zugang zu erhalten

Excerpt

Dear editor, …

Vorheriger Artikel COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease

Nächster Artikel Sampling site matters when testing for COVID-19 after total laryngectomy: a case report

Sanyaolu A, Okorie C, Marinkovic A, et al. Comorbidity and its impact on patients with COVID-19. SN Compr Clin Med. 2020; https://doi.org/10.1007/s42399-020-00363-4.CrossRefPubMedPubMedCentral

Hariyanto TI, Kurniawan A. Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Diabetes Metab Syndr. 2020;14(5):1429–30. https://doi.org/10.1016/j.dsx.2020.07.044.CrossRefPubMedPubMedCentral

Dworakowska D, Grossman AB. Thyroid disease in the time of COVID-19. Endocrine. 2020;68(3):471–4. https://doi.org/10.1007/s12020-020-02364-8.CrossRefPubMed

Chen M, Zhou W, Xu W. Thyroid function analysis in 50 patients with COVID-19: a retrospective study. Thyroid. 2020; https://doi.org/10.1089/thy.2020.0363.CrossRefPubMedPubMedCentral

Dosi R, Jain G, Mehta A. Clinical characteristics, comorbidities,and outcome among 365 patients of coronavirus disease 2019 at a tertiary care centre in central India. J Assoc Physicians India. 2020;68(9):20–3.PubMed

Titel: Is there an association between hypothyroidism and COVID 19?
A preliminary report
verfasst von: Associate professor of ENT Dr Satvinder Singh Bakshi, MS, DNB
Dr. Vinoth Kumar Kalidoss, MD MPH
Publikationsdatum: 03.02.2021
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 7-8/2021
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-021-01813-2

Springer Medizin Österreich

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7-8/2021

Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers

6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort

Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients

Veranstaltungstipps:

Effect of early oseltamivir on outpatients without hypoxia with suspected COVID-19

COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease